Recommendations Developed for Assessing Postoperative Crohn Disease Recurrence

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 28, 2026.

via HealthDay

THURSDAY, May 28, 2026 -- Multidisciplinary recommendations are presented to standardize intestinal ultrasound application for assessing postoperative recurrence of Crohn disease in an article published online May 20 in The Lancet Gastroenterology & Hepatology.

Christopher Ma, M.D., from The Cumming School of Medicine in Calgary, Alberta, Canada, and colleagues developed expert-based recommendations for standardizing intestinal ultrasound use for the detection and evaluation of postoperative Crohn disease recurrence after surgical bowel ileocolic resection. A list of statements related to the use of intestinal ultrasound in this setting was generated; the appropriateness of each statement was rated in two rounds of voting and classified as appropriate, inappropriate, or uncertain and then ratified.

The researchers found that during the ratification meeting, 79 statements were voted on; 67 were ratified. The colonic segment immediately distal to the anastomosis, the neoterminal ileum, neoterminal ileal inlet, colonic and ileal blind side of the anastomosis, sonographically visible colonic segments, and the surrounding mesentery were recommended anatomical components for sonographic evaluation. For parameters of assessment, the authors recommended bowel wall thickness, bowel wall stratification, bowel wall vascularity, mesenteric inflammatory fat and lymphadenopathy, luminal narrowing, and the presence of complications (abscess, inflammatory mass, fistula or sinus tract, stricture and stricture length, and prestenotic dilation). To avoid confounding the interpretation of sonographic findings with immediate postoperative complications or changes associated with surgical healing, waiting at least four weeks after surgery to perform intestinal ultrasound was recommended.

"The guidance developed through this consensus aims to enhance consistency, diagnostic accuracy, and confidence in applying intestinal ultrasound to clinical practice and research settings," the authors write.

Several authors disclosed ties to biopharmaceutical companies, including Johnson & Johnson Innovative Medicine, which funded the research.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-05-29 03:14

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords